My Cart

Carbonic Anhydrase IX

Carbonic Anhydrase IX Overview

English NameCarbonic anhydrase IXApproved Drugs0
Drugs in Clinical Trials15Target SynonymEC:4.2.1.1,Renal cell carcinoma-associated antigen G250,P54/58N,CA9,Carbonic Anhydrase 9,RCC-Associated Protein G250,Carbonate Dehydratase IX,Carbonic Dehydratase,CA-IX,CAIX,PMW1,MN,EC 4.2.1.1,G250,Carbonic anhydrase IX,Membrane antigen MN,RCC-associated antigen G250
Highest Development StagePhase 3 Clinical
English NameCarbonic anhydrase IX
Target SynonymEC:4.2.1.1,Renal cell carcinoma-associated antigen G250,P54/58N,CA9,Carbonic Anhydrase 9,RCC-Associated Protein G250,Carbonate Dehydratase IX,Carbonic Dehydratase,CA-IX,CAIX,PMW1,MN,EC 4.2.1.1,G250,Carbonic anhydrase IX,Membrane antigen MN,RCC-associated antigen G250
Approved Drugs0
Drugs in Clinical Trials15
Highest Development StagePhase 3 Clinical

Carbonic Anhydrase IX Product List

  • Product Category

    Protein (11)

  • Product Status

    Launched (11)

  • Species

    Human (8)Mouse (1)Cynomolgus (2)

  • Tag

    His Tag (7)His Tag & Avi Tag (2)Fc Tag (1)Fc Tag & Avi Tag (1)

  • Conjugate

    Unconjugated (5)Biotin-labeled (3)PE Labeled (1)FITC Labeled (1)APC Labeled (1)

Carbonic Anhydrase IX Background

Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes. CAs form a family of enzymes that catalyze the rapid interconversion of carbon dioxide and water to bicarbonate and protons (or vice versa), a reversible reaction that occurs rather slowly in the absence of a catalyst. One of the functions of the enzyme in animals is to interconvert carbon dioxide and bicarbonate to maintain acid-base balance in blood and other tissues, and to help transport carbon dioxide out of tissues. The active site of most carbonic anhydrases contains a zinc ion. There are at least five distinct CA families (α, β, γ, δ and ε). Carbonic anhydrase 9 (CA9 / CAIX) is also known as Membrane antigen MN (MN), Renal cell carcinoma-associated antigen G250, which belongs to the alpha-carbonic anhydrase family. CA9 / CAIX with an optimal activity at pH 6.49. Reversible hydration of carbon dioxide. CA IX participates in pH regulation. CA9 may be involved in the control of cell proliferation and transformation. CA-IX appears to be a novel specific biomarker for a cervical neoplasia.

Carbonic Anhydrase IX Synonyms

CAIX,CA9,CA-IX,G250,MN,P54,58N,pMW1

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Girentuximab MAb-G250; cG250; WX-G250Phase 3 ClinicalWilex AGKidney Neoplasms; Carcinoma, Renal Cell
Details
Girentuximab-Zr-8989Zr-TX250; TLX-250-CDx; 89Zr-TX-250; TLX250-CDx; 89Zr-TLX250Phase 3 ClinicalWilex AGUrinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Uterine Cervical Neoplasms; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Contrast agents; Nasopharyngeal Carcinoma; Cholangiocarcinoma; Sarcoma; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Triple Negative Breast Neoplasms; Carcinoma, Ovarian Epithelial; Glioblastoma; Small Cell Lung Carcinoma; Stomach Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck
Details
Lutetium-177 DOTA girentuximabTLX-250Phase 2 ClinicalWilex AG, Heidelberg, Telix Pharmaceuticals LtdCarcinoma, Renal Cell; Neoplasms
Details
[177Lu]Lu-DPI-4452[177Lu]Lu-DPI-4452; Debio 0228; ITM-91; 3BP-4452Phase 2 Clinical3B Pharmaceuticals GmbHCarcinoma, Renal Cell; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal
Details
Debio-0328ITM-94D; [68Ga]Ga-DPI-4452; Gallium-68-DPI-4452Phase 2 Clinical3B Pharmaceuticals GmbHCarcinoma, Renal Cell; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal
Details
68Ga-NY10468Ga-NY-104; 68Ga-NYM005Phase 2 ClinicalWuxi Nuoyu Pharmaceutical Technology Co LtdCarcinoma, Renal Cell
Details
PMI-05PMI-05Phase 1 ClinicalPrecision Molecular IncNeoplasms
Details
PHC-102PHC102; 99mTc-CAIXPhase 1 ClinicalPhilochemCarcinoma, Renal Cell
Details
Indium-111-DOTA-girentuximab-IRDye800CW (Radboud University)Phase 1 ClinicalRadboud University NijmegenCarcinoma, Renal Cell; Diagnostic agents
Details
Indium-111-DOTA-girentuximab-IRDye800CW111In-girentuximab-F2Phase 1 ClinicalHead and Neck Neoplasms; Carcinoma, Renal Cell
Details
[68Ga]Ga-OncoCAIX[68Ga]Ga-OncoCAIXPhase 1 ClinicalPhilogen SpaCarcinoma, Renal Cell
Details
18F-NY10418F-NY104; 18F-NYM005Phase 1 ClinicalWuxi Nuoyu Pharmaceutical Technology Co LtdCarcinoma, Renal Cell; Contrast agents
Details
CA9hu-1CA9hu-1Phase 1 ClinicalMabpro ASHead and Neck Neoplasms; Carcinoma, Renal Cell; Triple Negative Breast Neoplasms; Mesothelioma; Carcinoma, Non-Small-Cell Lung
Details
Sulfamide-nitroimidazoleClinicalDualtpharmaNeoplasms
Details
PD-32766PD-32766; 64Cu-PD-32766; 225Ac-PD-32766ClinicalPeptiDream IncOvarian Neoplasms; Solid tumours; Carcinoma, Renal Cell; Glioblastoma; Triple Negative Breast Neoplasms; Colorectal Neoplasms
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland